reports
- GlobalData Healthcare Department
Capricor Therapeutics Inc (CAPR) - Financial Analysis Review
Summary Capricor Therapeutics Inc (CAPR) - Financial Analysis Review Summary Capricor Therapeutics Inc (Capricor) is a clinical-stage biotechnology company that discovers, develops and commercializes therapeutics for cardiac and various diseases. It offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced heart failure and duchenne muscular dystrophy associated cardiomyopathy. The company's lead product CAP- 1002, is in phase II clinical s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.